The Role of Simulation-Based Learning in Medicine 

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Introduction Education of health professionals should not only be learning content centered, but should also expand to include a method for hands-on learning, especially in the current fast-paced health care climate. The use of the simulation is a powerful learning tool that allows practitioners to gain hands-on experience in a safe environment. It’s true, as […]

The post The Role of Simulation-Based Learning in Medicine  appeared first on Medical News Bulletin.

Everything Doctors Wish Their Patients Understood About Staying Hydrated

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Physicians the country over have the same discussion every year in their clinical practice. A patient suffers from fatigue, headaches, difficulty concentrating or muscle cramps. The workup is relatively normal.  But in the course of the review of daily habits, the issue of hydration is raised and then, it’s an answer that is not complicated […]

The post Everything Doctors Wish Their Patients Understood About Staying Hydrated appeared first on Medical News Bulletin.

Bulletin: Finerenone Trial Results in For Non-diabetic Kidney Disease

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Finerenone has been helping patients with diabetic chronic kidney disease for some time, and now the drug may soon be available to patients with non-diabetic kidney diseases too. In a June 2026 JAMA paper, researchers report the results of part of the FIND-CKD phase 3 clinical trial. This study tested how well Finerenone performed in patients […]

The post Bulletin: Finerenone Trial Results in For Non-diabetic Kidney Disease appeared first on Medical News Bulletin.

FDA clears OTC CGM for children aged 2 years and older

The FDA has announced additional marketing clearance for the Dexcom Stelo Glucose Biosensor System for children aged 2 years and older, according to a press release.
The Dexcom Stelo Glucose Biosensor System received FDA marketing clearance for adults in March 2024. The clearance now extends to children aged 2 years and older.
According to the release, the integrated CGM is indicated for adults and children, including those with diabetes, who do not take insulin but may take oral medication to manage their condition. The OTC device may also be used by adults, as well as children and their

Study: Kids with fall birthdays more likely to get flu vaccine

Children with fall birthdays are more likely to get vaccinated against influenza and less likely to be diagnosed with flu compared with peers who have summer birthdays, according to findings published in JAMA Pediatrics.
Christopher M. Worsham, MD, MPH, a health services researcher at Harvard Medical School, said the motivation for the study was the federal government removing influenza vaccines — and many others — from the list of universally recommended vaccines for children, a move that has been temporarily blocked by a federal judge. President Donald J. Trump signed an executive order in

Impact of legalizing cannabis on psychosis unknown

Although cannabis has been associated with psychosis, variations in studies driven by shifting policies have led to mixed results, according to a review presented at the American Psychiatric Association Annual Meeting in San Francisco.
These heterogeneous findings indicate a need for a comprehensive synthesis of research that would inform further changes in policy, Jeonghyun Shin, MD, a first-year psychiatry resident at Maimonides Medical Center in New York, said during the presentation with study co-authors Jamie Baik, MD, MEd, second-year resident, Cambridge Health Alliance, and Elif Ozan,

FDA approves belzutifan, pembrolizumab for renal cell carcinoma

The FDA approved belzutifan with pembrolizumab as an adjuvant treatment for adults with clear cell renal cell carcinoma and a high risk for recurrence after nephrectomy, according to a press release.
The approval allows belzutifan (Welireg, Merck) to be used in combination with pembrolizumab (Keytruda, Merck) or pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex, Merck).
According to the release, the treatment is designed for “adults with renal cell carcinoma with a clear cell component who are at intermediate-high or high risk of recurrence following nephrectomy or following

Dynamic duo: The strengths of ID provider-pharmacist collaboration

From the rarest conditions to the pandemics that affect societal norms, infections are abundant in everyday life.
Although some infections are more straightforward than others, having an expert in infectious diseases on the interdisciplinary care team can be crucial in many severe infections. Not only can an ID consult service assist in management of the infection itself, but ID providers lend expertise to end-of-life care for critically ill and medically complex patients and affect local epidemiology through continued antimicrobial stewardship efforts.
Bloodstream infections, including

Achieve professional growth through ‘purposeful imbalance’

An unconventional, nonstandard career path in ophthalmology can result in a unique skill set and stronger doctors.
In this episode of Steeped Insights, a video blog series produced by Women in Ophthalmology and Healio, host Karen Chen, MD, of Permanente Medical Group, and cohost Cynthia A. Bradford, MD, formerly of Dean McGee Eye Institute, sat down with Mahsaw Mansoor, MD, Masket Foundation fellow at Advanced Vision Care. Over a cup of tea, the physicians discussed how Mansoor’s decision to pursue a second fellowship gave her more clarity on what she wanted out of her career.
{{VIDEO}}
“I

New e-book is ‘chairside reference’ for nutrition in eye care

Nutrition can be a significant factor in the management of ocular diseases, but are doctors incorporating that into their care?
A recently published e-book aims to be a guide to ocular nutrition that optometrists can refer to in daily practice.
“Ocular Nutrition Handbook for the Practicing Optometrist” offers nutritional advice for more than 30 conditions, from age-related macular degeneration, glaucoma and dry eye to less common presentations such as Graves’ disease and central serous retinopathy. It lists dosages and directions for use and highlights what advice should be